Mark Howard Snyder - SVP, CHIEF LEGAL OFFICER at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Chief Legal Officer
Stock Symbol
HALO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Howard Snyder since 9/18/2023

Holdings reported by Mark Howard Snyder for Halozyme Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 20.1K $1.02M $50.62 Jun 12, 2024 Direct Common Stock
Common Stock 11.7K $422K $36.10 Feb 16, 2024 Direct
Option to Purchase Common Stock 29.1K $403K $13.87 Feb 23, 2024 Direct Common Stock

Transactions reported by Mark Howard Snyder for Halozyme Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.